The latest Investing Matters Podcast episode with multi-award-winning fund manager and international bestselling author Lee Freeman-Shor has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJp Morg.chin Regulatory News (JCGI)

Share Price Information for Jp Morg.chin (JCGI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 220.00
Bid: 219.00
Ask: 222.00
Change: 0.00 (0.00%)
Spread: 3.00 (1.37%)
Open: 220.00
High: 220.00
Low: 220.00
Prev. Close: 220.00
JCGI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

27 Jul 2021 13:11

RNS Number : 6407G
JPMorgan China Growth & Income PLC
27 July 2021
 

JPMORGAN CHINA GROWTH & INCOME PLC

 

DIRECTORATE CHANGE

 

 

Legal Entity Identifier: 549300S8M91P5FYONY25

Information disclosed in accordance with the LR 9.6.13 (1) - (6)

 

 

As part of its long-term succession plan, the Board of JPMorgan China Growth & Income plc (the 'Company') is pleased to announce its intention to appoint Ms. May Siew Boi Tan as an independent non-executive Director of the Company with effect from 2nd August 2021.

 

A Hong Kong resident, Ms. Tan has over 30 years of experience in the investment industry. Ms. Tan qualified as a chartered accountant with PwC before embarking on a career as an equity and corporate finance specialist with Cazenove Asia from 1984-2009. Ms. Tan served as the CEO of Cazenove Asia (1993-2009). When Cazenove Asia became part of Standard Chartered Bank (SCB) in 2009, Ms. Tan assumed the role of head of equity corporate finance at SCB from 2009-2013. She was appointed the CEO of SCB (Hong Kong) Limited in 2014 and retired in 2017.

 

Ms. Tan will strengthen the Board's depth of understanding and oversight of developments in the Chinese economy and equity markets.

 

No further information is to be disclosed in respect of paragraphs 9.6.13 (1) - (6) of the UKLA Listing Rules for Ms. Tan.

 

In line with the Company's Board Succession plan, Mr. Oscar Wong will be standing down as a Director with immediate effect.

Commenting on the departure of Mr. Wong, Mr. John Misselbrook, the Company's Chairman, said:

"I and the Board offer our thanks for the valuable service that Mr. Wong has provided to the Company as Director and wish him well for the future."

Mr. David Graham will succeed Mr. Wong as Chairman of the Remuneration Committee.

 

27th July 2021

 

For further information, please contact:

Lucy Dina

JPMorgan Funds Limited - Secretary

020 7742 4000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABDGDRGBDDGBR
Date   Source Headline
4th Jul 202410:50 amRNSNet Asset Value(s)
3rd Jul 202410:23 amRNSNet Asset Value(s)
2nd Jul 202410:56 amRNSNet Asset Value(s)
1st Jul 20242:21 pmRNSGearing Announcement
1st Jul 20241:29 pmRNSDividend Declaration
1st Jul 202412:29 pmRNSNet Asset Value(s)
28th Jun 202410:53 amRNSNet Asset Value(s)
27th Jun 202410:36 amRNSNet Asset Value(s)
26th Jun 202410:34 amRNSNet Asset Value(s)
25th Jun 202411:04 amRNSNet Asset Value(s)
24th Jun 20243:46 pmRNSHolding(s) in Company
24th Jun 20242:44 pmRNSCHANGE OF COMPANY REGISTRAR
24th Jun 202411:42 amRNSBlock listing Interim Review
24th Jun 202411:30 amRNSGearing Announcement
24th Jun 202410:40 amRNSNet Asset Value(s)
21st Jun 202410:55 amRNSNet Asset Value(s)
20th Jun 202410:54 amRNSNet Asset Value(s)
19th Jun 202410:43 amRNSNet Asset Value(s)
18th Jun 202410:43 amRNSNet Asset Value(s)
17th Jun 202411:16 amRNSGearing announcement
17th Jun 202410:40 amRNSNet Asset Value(s)
14th Jun 202411:02 amRNSNet Asset Value(s)
13th Jun 202410:37 amRNSNet Asset Value(s)
13th Jun 20249:45 amRNSTen Largest Investments
12th Jun 202410:26 amRNSNet Asset Value(s)
11th Jun 202410:29 amRNSNet Asset Value(s)
10th Jun 202411:54 amRNSGearing announcement
10th Jun 202411:11 amRNSNet Asset Value(s)
7th Jun 202410:39 amRNSNet Asset Value(s)
6th Jun 202410:45 amRNSNet Asset Value(s)
5th Jun 202410:47 amRNSNet Asset Value(s)
4th Jun 202411:02 amRNSNet Asset Value(s)
3rd Jun 202412:02 pmRNSGearing Announcement
3rd Jun 202410:55 amRNSNet Asset Value(s)
31st May 202411:04 amRNSNet Asset Value(s)
30th May 202410:22 amRNSNet Asset Value(s)
29th May 202412:48 pmRNSHalf-year Report
29th May 202410:34 amRNSNet Asset Value(s)
28th May 202411:41 amRNSGearing Announcement
28th May 202411:08 amRNSNet Asset Value(s)
24th May 202410:37 amRNSNet Asset Value(s)
23rd May 202410:36 amRNSNet Asset Value(s)
22nd May 202411:08 amRNSNet Asset Value(s)
21st May 202411:39 amRNSNet Asset Value(s)
20th May 202411:56 amRNSGearing Announcement
20th May 202410:45 amRNSNet Asset Value(s)
17th May 202410:40 amRNSNet Asset Value(s)
16th May 202410:37 amRNSNet Asset Value(s)
16th May 20249:30 amRNSDirector Declaration
15th May 202410:25 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.